Advertisements


Why 4 Top Biotech Stocks May Be the Next Takeover Targets

These four top companies could be very attractive to large cap biotechs looking to add gene and cell therapy drugs to their portfolios......»»

Category: blogSource: 247wallstApr 16th, 2018

Jeff Reeves"s Strength in Numbers: Three tech, three biotech companies that are top takeover targets in 2019

Corporate America has been willing to pay big bucks for takeovers......»»

Category: topSource: marketwatchJan 10th, 2019

Eli Lilly CEO Predicts 2019 Will Be Big Year for Biotech Acquisitions

Latest deals seem to have driven up prices of targets. Some may be good shortsRelated Stocks: LLY, LOXO, BAYN, MRK, ILMN, BMY, CELG, ACOR, BIIB, ALNY, SNY,.....»»

Category: blogSource: gurufocusJan 14th, 2019

The Biotech Rebound Is Just Beginning

Health care and biotech stocks are poised to take off in the years to come, thanks to new technologies and medicines......»»

Category: topSource: redinewsApr 15th, 2024

The Week Ahead In Biotech (May 23-29): Eton, Lantheus FDA Decisions, Adcom Test For Provention, Chiasma Data Presentation

Biotech stocks advanced in the week ended May 21, as risk aversion forced traders to buy into defensives. As earnings news flow tapered, stocks took cues from clinical readouts. read more.....»»

Category: blogSource: benzingaMay 23rd, 2021

The Daily Biotech Pulse: Moderna"s Vaccine Authorized In Japan, Neovasc"s Adverse Ruling In Germany, Metacrine Rallies On Insider Buying

Here's a roundup of top developments in the biotech space over the last 24 hours. Scaling The Peaks (Biotech Stocks Hitting 52-week Highs May 20) read more.....»»

Category: blogSource: benzingaMay 21st, 2021

The Week Ahead In Biotech: Sanofi, Bristol-Myers Squibb Await FDA Decisions, Earnings News Flow Tapers Off

Biotech stocks had a volatile ride in the week ended May 14, with stocks moving broadly lower for much of the week before coming back up strongly in the final session. Some of the weakness may be traced back to the across-t.....»»

Category: dealsSource: nytMay 16th, 2021

The Week Ahead In Biotech: Sanofi, Bristol-Myers Squibb Await FDA Decisions, Earnings News Flow Tapers Off

Biotech stocks had a volatile ride in the week .....»»

Category: blogSource: benzingaMay 15th, 2021

The Funded: Bay Area biotech Vera Therapeutics" IPO priced well short of targets, another sign of a worsening market

Vera's disappointing offering follows several others that have been postponed or also missed their price targets......»»

Category: topSource: bizjournalsMay 14th, 2021

The Funded: Bay Area biotech Vera Therapeutics" IPO just well short of targets, another sign of a worsening market

Vera's disappointing offering follows several others that have been postponed or also missed their price targets......»»

Category: topSource: bizjournalsMay 14th, 2021

The Week Ahead In Biotech (May 9-15): Heron, Apellis FDA Decisions, Presentations and Earnings

Biotech stocks came under pressure in the week ended May 7 as traders digested a slew of earnings news flow and a handful of clinical trial readouts. COVID-19 vaccine stocks came under pressure following the U.S. read more.....»»

Category: blogSource: benzingaMay 9th, 2021

Week Ahead In Biotech (May 2-8): ChemoCentryx Adcom, Ophthalmology Conference Presentations, Earnings Deluge

Biopharma stocks experienced volatility in the week ended April 30, as stocks reacted to earnings, data readouts and a handful of FDA decisions. read more.....»»

Category: blogSource: benzingaMay 1st, 2021

The Daily Biotech Pulse: Hyperphosphatemia Drug Regulatory Review Extended, Phathom Pharma Data Readout, 2 IPOs

Here's a roundup of top developments in the biotech space over the last 24 hours. Scaling The Peaks (Biotech Stocks Hitting 52-week Highs April 29) read more.....»»

Category: blogSource: benzingaApr 30th, 2021

The Daily Biotech Pulse: FDA Rejection For Protalix, Amgen Q1 Trail Estimates, Pfizer Goes Shopping

Here's a roundup of top developments in the biotech space over the last 24 hours. Scaling The Peaks (Biotech Stocks Hitting 52-week Highs April 27) read more.....»»

Category: blogSource: benzingaApr 28th, 2021

The Daily Biotech Pulse: Q1 Beat From Johnson & Johnson, KalVista Study Placed On Hold, European Label Expansion For GW Pharma"s Epidiolex

Here's a roundup of top developments in the biotech space over the last 24 hours: Scaling The Peaks (Biotech Stocks Hitting 52-week Highs April 15) read more.....»»

Category: blogSource: benzingaApr 20th, 2021

Purple Biotech Stock Gives Every Indication Of Being Modestly Overvalued

Related Stocks: PPBT,.....»»

Category: blogSource: gurufocusApr 18th, 2021

The Week Ahead In Biotech: Johnson & Johnson, Biogen Earnings, Neurology Conference And IPOs

Biotech stocks reversed course in the week ended April 16, with the sector re.....»»

Category: blogSource: benzingaApr 17th, 2021

Morgan Stanley Sees Plenty of Lift in Airline Stocks

Morgan Stanley analysts boosted price targets Tuesday morning on several U.S. airlines and initiated coverage of one with an Underweight rating that already has outrun the analysts' target......»»

Category: blogSource: 247wallstApr 6th, 2021

Trinity Biotech PLC Stock Gives Every Indication Of Being Significantly Overvalued

Related Stocks: TRIB,.....»»

Category: blogSource: gurufocusApr 4th, 2021

5 Small-Cap Biotech Stocks Trading Under $10 With Massive Upside Potential

These five super-aggressive biotech stocks are all rated Buy at well-known Wall Street firms and are suitable for very aggressive investors that have a high-risk tolerance......»»

Category: blogSource: 247wallstApr 4th, 2021

The Week Ahead In Biotech: Regeneron, Supernus FDA Decisions, Cancer Conference Presentations In The Spotlight

Biotech stocks ended the holiday-shortened week ended April 1 in the green, catalyzed by the broader market rebound and a slew of company-specific news flow. Buoyed by hopes of a U.S. read more.....»»

Category: blogSource: benzingaApr 3rd, 2021